Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹101.64 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹101.64 Cr |
| Fresh Issue | ₹59.53 Cr |
| Offer for Sale | ₹36.30 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹121.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543346 |
| Registrar | Accurate Securities & Registry... |
| Lead Managers | Fedex Securities Pvt.Ltd. |
| Allotment Status |
| DRHP |
| RHP |
| Final Prospectus |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Incorporated in 2012, Aashka Hospital, the Gujarat-based hospital is an integrated healthcare service provider that offers the best quality of healthcare facilities including prevention, best treatment, and rehabilitation.It serves a range of healthcare services i.e. Cardiology, neurology, neurosurgery, nephrology, anesthesiology, orthopedics, pediatric services, neonatology services, dermatology, radiology, dentistry, obstetrics, and gynecology, and more.
It serves patients with ultra-modern medicinal practices and state-of-the-art infrastructure for medical as well as surgical care solutions. Amid COVID-19, it has set up a designated COVID-19 Treatment hospital and treated 2,000+ patients.
Competitive strengths
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment / prepayment, in full or part, of certain borrowings availed by thr Company; | 20.00 |
| 2 | Funding of our inorganic growth initiatives | 28.54 |
| 3 | General corporate purposes | 15.00 |
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 65.08 | 60.05 | 54.05 |
| Total Income | 40.69 | 27.25 | 27.73 |
| Profit After Tax | 4.11 | 1.38 | 1.36 |
| EBITDA | 9.92 | 8.62 | 9.57 |
| NET Worth | 29.25 | 24.19 | 15.36 |
| Reserves and Surplus | 11.25 | 6.28 | -1.80 |
| Total Borrowing | 21.67 | 27.39 | 25.52 |
| Amount in ₹ Crore | |||
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manager Fees including Underwriting Commission | 0.50 |
| 2 | Brokerage, Selling, Commission and upload fees | 0.25 |
| 3 | Registrar to the Issue | 0.00 |
| 4 | Legal and Other Advisory Services | 0.01 |
| 5 | Advertising and marketing Expenses | 1.85 |
| 6 | Regulators including Stock Exchange | 0.06 |
| 7 | Printing and Distribution of issue stationery | 0.01 |
| 8 | Others, if any (Market making, depositories, marketing fees, secretarial, peer reviewed auditors etc.) | 0.13 |
Last Updated on 26-Jun-2026 10:58:35
